7Centers for Disease Control and Prevention (CDC). Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation: United States, 2010-2012[J]. Morbidity and Mortality Weekly Report, 2013, 62(44): 869-873.
8MOYER R F, RATNESWARAN A, BEIER F, et al. Osteoarthritis year in review 2014: mechanics-basic and clinical studies in osteoarthritis[J]. Osteoarthritis and Cartilage, 2014, 22(12): 1989-2002.
9BRUYERE O, REGINSTER J Y. Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis[J]. Drugs and Aging, 2007, 24(7): 573-580.
10van der ESCH M, KNOOP J, van der LEEDEN M, et al. Clinical phenotypes in patients withknee osteoarthritis: a study in the Amsterdam osteoarthritis cohort[J]. Osteoarthritis and Cartilage, 2015, 23: 544-549.
